NO137894C - Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer

Info

Publication number
NO137894C
NO137894C NO750104A NO750104A NO137894C NO 137894 C NO137894 C NO 137894C NO 750104 A NO750104 A NO 750104A NO 750104 A NO750104 A NO 750104A NO 137894 C NO137894 C NO 137894C
Authority
NO
Norway
Prior art keywords
amidoximes
preparation
pharmacologically active
analogical procedure
analogical
Prior art date
Application number
NO750104A
Other languages
English (en)
Norwegian (no)
Other versions
NO750104L (de
NO137894B (no
Inventor
Fernand Binon
Pierre Eymard
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz filed Critical Labaz
Publication of NO750104L publication Critical patent/NO750104L/no
Publication of NO137894B publication Critical patent/NO137894B/no
Publication of NO137894C publication Critical patent/NO137894C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO750104A 1974-01-15 1975-01-14 Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer NO137894C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7401286A FR2257273B1 (de) 1974-01-15 1974-01-15

Publications (3)

Publication Number Publication Date
NO750104L NO750104L (de) 1975-08-11
NO137894B NO137894B (no) 1978-02-06
NO137894C true NO137894C (no) 1978-05-24

Family

ID=9133487

Family Applications (1)

Application Number Title Priority Date Filing Date
NO750104A NO137894C (no) 1974-01-15 1975-01-14 Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer

Country Status (23)

Country Link
US (1) US3931240A (de)
JP (1) JPS541301B2 (de)
AR (1) AR201414A1 (de)
AT (1) AT340912B (de)
BE (1) BE824227A (de)
CA (1) CA1037960A (de)
CH (1) CH593245A5 (de)
DE (1) DE2501122C3 (de)
DK (1) DK137953B (de)
ES (1) ES433816A1 (de)
FI (1) FI63746C (de)
FR (1) FR2257273B1 (de)
GB (1) GB1462311A (de)
HU (1) HU168062B (de)
IE (1) IE40883B1 (de)
IT (1) IT1044267B (de)
NL (1) NL166020C (de)
NO (1) NO137894C (de)
OA (1) OA04881A (de)
SE (1) SE422202B (de)
SU (1) SU545254A3 (de)
YU (1) YU36495B (de)
ZA (1) ZA748105B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422630A1 (fr) * 1978-04-14 1979-11-09 Synthelabo Derives de propionamidoxime et leur application en therapeutique
FR2506767A1 (fr) 1981-05-26 1982-12-03 Synthelabo Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique
FR2506764A1 (fr) * 1981-05-26 1982-12-03 Synthelabo Derives d'amidoximes, leur preparation et leur application en therapeutique
JPS58131482A (ja) * 1982-01-29 1983-08-05 Matsushita Electric Ind Co Ltd リフト型逆止弁
US4851554A (en) * 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4806663A (en) * 1987-04-06 1989-02-21 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4831156A (en) * 1987-09-30 1989-05-16 The University Of Tennessee Research Corp. 3-substituted 2-alkyl indole derivatives
AU5257401A (en) * 2000-04-28 2001-11-12 Asahi Chemical Ind Novel bicyclic compounds

Also Published As

Publication number Publication date
YU349874A (en) 1982-02-25
DK137953C (de) 1978-12-18
ZA748105B (en) 1976-01-28
NL166020B (nl) 1981-01-15
AT340912B (de) 1978-01-10
FR2257273A1 (de) 1975-08-08
HU168062B (de) 1976-02-28
CA1037960A (en) 1978-09-05
DK645174A (de) 1975-09-08
FI353674A (de) 1975-07-16
NO750104L (de) 1975-08-11
DK137953B (da) 1978-06-12
SE422202B (sv) 1982-02-22
NL7500399A (nl) 1975-07-17
AU7665374A (en) 1976-06-24
IT1044267B (it) 1980-03-20
IE40883B1 (en) 1979-09-12
FI63746C (fi) 1983-08-10
NL166020C (nl) 1981-06-15
GB1462311A (en) 1977-01-26
JPS541301B2 (de) 1979-01-23
SE7500360L (de) 1975-07-16
FR2257273B1 (de) 1978-01-13
AR201414A1 (es) 1975-03-07
BE824227A (fr) 1975-07-09
US3931240A (en) 1976-01-06
CH593245A5 (de) 1977-11-30
JPS50101348A (de) 1975-08-11
YU36495B (en) 1984-02-29
IE40883L (en) 1975-07-15
ES433816A1 (es) 1976-09-16
DE2501122C3 (de) 1982-03-18
FI63746B (fi) 1983-04-29
DE2501122B2 (de) 1981-05-21
SU545254A3 (ru) 1977-01-30
DE2501122A1 (de) 1975-07-17
NO137894B (no) 1978-02-06
ATA26875A (de) 1977-05-15
OA04881A (fr) 1980-10-31

Similar Documents

Publication Publication Date Title
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO157933C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser.
NO138805C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO141717C (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive triazolopyridaziner
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO137894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer
NO140824C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener
NO810816L (no) Utgangsmateriale for fremstilling av terapeutisk aktive aminosyrederivater
NO143317C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazindioksyder
NO137151C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO138250C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylaminer
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO139733C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
SE414029B (sv) Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat
SE404926B (sv) Analogiforfarande for framstellning av 3-piperazin-isokinoliner